協和キリン
4151
東証プライム
医薬品
協和キリンの決算推移
損益計算書
(単位:百万円)
2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
---|---|---|---|---|---|---|---|---|---|---|---|
売上高 | 333,446 | 364,316 | 343,019 | 353,380 | 346,531 | 305,820 | 318,352 | 352,246 | 398,371 | 442,233 | 495,558 |
売上原価 | 127,542 | 138,922 | 134,526 | N/A | N/A | 79,620 | 80,440 | 87,849 | 86,915 | 111,207 | 132,611 |
売上総利益 | 205,904 | 225,393 | 208,493 | N/A | N/A | 226,200 | 237,912 | 264,398 | 311,455 | 331,026 | 362,947 |
販管費 | 169,731 | 181,628 | 176,854 | N/A | N/A | 117,316 | 126,610 | 145,608 | 166,185 | 163,078 | 167,537 |
営業利益 | 36,173 | 43,765 | 31,638 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
営業外収益 | 2,305 | 2,927 | 3,738 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
営業外費用 | 8,966 | 7,489 | 8,978 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
経常利益 | 29,511 | 39,203 | 26,397 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
特別利益 | 308 | 8,168 | 4,707 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
特別損失 | 2,575 | 5,971 | 816 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
当期純利益 | 15,898 | 29,774 | 18,669 | 42,899 | 54,414 | 67,084 | 47,027 | 52,347 | 53,573 | 81,188 | 59,870 |
貸借対照表
(単位:百万円)
2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
---|---|---|---|---|---|---|---|---|---|---|---|
資産 | 719,135 | 720,764 | 697,167 | 708,295 | 741,982 | 784,453 | 801,290 | 921,872 | 939,881 | 1,025,942 | 1,067,363 |
流動資産 | 283,192 | 324,433 | 326,469 | N/A | N/A | 448,610 | 442,482 | 518,231 | 542,189 | 611,124 | 504,026 |
現金及び預金 | 20,657 | 13,236 | 13,066 | 14,685 | 15,867 | 20,762 | 287,019 | 335,084 | 339,194 | 403,083 | 244,681 |
売上債権 | 108,867 | 106,829 | 100,999 | N/A | N/A | 89,015 | 92,287 | 104,275 | 111,746 | 119,082 | 157,015 |
棚卸資産 | 91,283 | 84,804 | 76,228 | N/A | N/A | 47,123 | 51,281 | 64,089 | 70,675 | 71,363 | 72,933 |
固定資産 | 435,943 | 396,331 | 370,698 | N/A | N/A | 335,843 | 358,808 | 403,641 | 397,692 | 414,818 | 563,337 |
負債 | 113,766 | 105,906 | 96,422 | N/A | N/A | 106,204 | 102,894 | 184,710 | 177,055 | 189,524 | 216,551 |
流動負債 | 85,182 | 84,823 | 79,416 | N/A | N/A | 87,530 | 80,749 | 109,129 | 109,825 | 133,237 | 164,675 |
仕入債務 | 22,729 | 19,086 | 18,230 | N/A | N/A | 53,877 | 54,867 | 64,652 | 70,922 | 92,983 | 121,063 |
固定負債 | 28,584 | 21,082 | 17,006 | N/A | N/A | 18,673 | 22,145 | 75,581 | 67,229 | 56,287 | 51,876 |
純資産 | 605,368 | 614,858 | 600,745 | N/A | N/A | 678,250 | 698,396 | 737,162 | 762,826 | 836,418 | 850,811 |
利益剰余金 | 68,103 | 85,997 | 90,986 | N/A | N/A | 201,253 | 226,639 | 255,528 | 285,842 | 338,764 | 371,050 |
自己株式 | -26,675 | -26,881 | -26,889 | N/A | N/A | -3,792 | -3,545 | -3,359 | -3,177 | -2,933 | -5,887 |
キャッシュフロー計算書
(単位:百万円)
2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
---|---|---|---|---|---|---|---|---|---|---|---|
営業CF | 19,377 | 66,526 | 65,752 | 64,902 | 56,181 | 53,655 | 39,502 | 86,548 | 48,672 | 115,551 | 67,884 |
投資CF | 16,805 | -57,747 | -48,968 | -45,265 | -39,929 | -933 | 252,559 | -11,363 | -17,185 | -20,382 | -142,387 |
財務CF | -37,184 | -14,060 | -13,598 | -18,287 | -16,501 | -47,371 | -26,003 | -28,446 | -29,032 | -32,535 | -84,697 |
フリーCF | 36,182 | 8,779 | 16,784 | 19,637 | 16,252 | 52,722 | 292,061 | 75,185 | 31,487 | 95,169 | -74,503 |